---
title: "Double the GEM, amplify the power of A-shares"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39071413.md"
description: "$Bosera China Growth Enterprise Market Index Daily Leveraged (2X) Product (07234.HK)$Growth Enterprise Market Index (399006.SZ) The GEM has gained -1.21% year-to-datePerformance list of the top 20 constituent stocks by weight in the Shenzhen Growth Enterprise Market: Investment involves risks. Past investment performance is not necessarily indicative of future results. Investors should not base their investment decisions solely on the information contained in this material. The above information is for reference only and does not constitute and should not be regarded as an offer to subscribe or sell to anyone. Investors should read the relevant fund's prospectus and product key facts statement in detail before making any investment decision..."
datetime: "2026-03-05T02:08:25.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39071413.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39071413.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39071413.md)
author: "[博时国际](https://longbridge.com/en/profiles/16136055.md)"
---

# Double the GEM, amplify the power of A-shares

[$Bosera China GEM Index Daily Leveraged (2X) Product (07234.HK)](https://longbridge.com/quote/07234.HK)[$GEM Index (399006.SZ)](https://longbridge.com/quote/399006.SZ)The GEM Index has fallen -1.21% year-to-date.

Performance overview of the top 20 constituent stocks by weight in the Shenzhen GEM:

Investing involves risks. Past investment performance may not be indicative of future results. Investors should not base their investment decisions solely on the information contained herein. The above information is for reference only and does not constitute and should not be considered as an offer to subscribe for or sell any securities. Before making any investment decision, investors should read the relevant fund's prospectus and product key facts statement in detail, including the product features and risk factors contained therein. Investors should consider whether the product is suitable for them based on factors such as their investment experience, objectives, financial situation, and risk tolerance. Seek independent professional advice if necessary. The above information has not been reviewed by the Securities and Futures Commission of Hong Kong.

Issued by: Bosera International. No part of this document or any information contained herein may be photocopied, distributed, or reproduced without the consent of Bosera International.[$Contemporary Amperex Technology Co. Limited (300750.SZ)](https://longbridge.com/quote/300750.SZ)[$East Money Information Co., Ltd. (300059.SZ)](https://longbridge.com/quote/300059.SZ)[$Inovance Technology Co., Ltd. (300124.SZ)](https://longbridge.com/quote/300124.SZ)[$Zhongji Innolight Co., Ltd. (300308.SZ)](https://longbridge.com/quote/300308.SZ)[$Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)](https://longbridge.com/quote/300760.SZ)[$Eoptolink Technology Inc., Ltd. (300502.SZ)](https://longbridge.com/quote/300502.SZ)[$Sungrow Power Supply Co., Ltd. (300274.SZ)](https://longbridge.com/quote/300274.SZ)[$Wens Foodstuff Group Co., Ltd. (300498.SZ)](https://longbridge.com/quote/300498.SZ)

### Related Stocks

- [07234.HK](https://longbridge.com/en/quote/07234.HK.md)
- [399006.CN](https://longbridge.com/en/quote/399006.CN.md)
- [300124.CN](https://longbridge.com/en/quote/300124.CN.md)
- [300760.CN](https://longbridge.com/en/quote/300760.CN.md)
- [300274.CN](https://longbridge.com/en/quote/300274.CN.md)